AIDS News and Research

RSS

Antiretroviral therapy may prevent some cancers in people with HIV

In people infected with human immunodeficiency virus (HIV), highly active antiretroviral therapy (HAART) may prevent most excess cases of Kaposi sarcoma and non-Hodgkin lymphoma, according to a new study in the March 16 issue of the Journal of the National Cancer Institute.

15 Mar 2005

Link between a critical cancer pathway and an Epstein-Barr Virus (EBV) protein

Researchers at the University of Pennsylvania School of Medicine have identified a link between a critical cancer pathway and an Epstein-Barr Virus (EBV) protein known to be expressed in a number of EBV-associated cancers.

15 Mar 2005

£800,000 to boost research into fighting viruses

A team of University of Glasgow scientists have received a grant of £800,000 from the Wellcome Trust to research a mechanism that blocks a critical step in the replication cycle of retroviruses. In the long term, the research could lead to the design of new therapeutic strategies or drugs against retroviruses, which cause diseases such as AIDS and certain leukemias.

14 Mar 2005

HIV-1 spread through six transmission lines in the UK

Contrary to the prevailing belief that the HIV epidemic in the UK can be traced back to one source, a new study suggests that HIV spread via at least six independent virus introductions and subsequent transmission chains.

14 Mar 2005

Study examines lessons learned at Africa's first public antiretroviral treatment clinic

A public clinic offering antiretroviral (ARV) treatment to people with HIV/AIDS, recently established in Botswana, has had its share of trials and errors. However, the obstacles it has encountered - and has largely overcome - can serve as valuable lessons for other developing countries trying to launch their own treatment programs, according to an article in the March 15 issue of Clinical Infectious Diseases.

14 Mar 2005

Naturally occurring antifungal agent in saliva kills oral pathogen responsible for most HIV-related oral infections

Oral biologists at the University at Buffalo have shown for the first time how histatin, the naturally occurring antifungal agent in saliva, kills the oral pathogen Candida albicans, the fungus responsible for most HIV-related oral infections.

14 Mar 2005

Discovery may provide a new target to treat sepsis

Part of the immune system's pro-inflammatory response to bacterial invasion is to increase nitric oxide levels with an enzyme called inducible nitric oxide synthase.

14 Mar 2005

China trials new HIV vaccine on humans

China which has 840,000 people with HIV, a conservative estimate say experts, will carry out the very first trials of a new virus on human guinea pigs.

13 Mar 2005

Half a billion cases of malaria occur each year

An international team of specialists in tropical medicine say at least half a billion cases of malaria occur each year, nearly 50% more than current estimates by World Health Organisation (WHO).

9 Mar 2005

Telomerase finding has major implications for cancer

UCLA biochemists have determined the three-dimensional structure of a major domain of telomerase, the enzyme that helps maintain telomeres - small pieces of DNA on the ends of chromosomes that act as protective caps - allowing DNA ends to be copied completely when cells are replicated.

9 Mar 2005

Study examines lessons learned at Africa's first public antiretroviral treatment clinic

A public clinic offering antiretroviral (ARV) treatment to people with HIV/AIDS, recently established in Botswana, has had its share of trials and errors.

9 Mar 2005

New MS drug withdrawn from the market

Two patients involved in clinical trials of Tysabri, have contracted a rare and fatal disease, Elan’s multiple sclerosis (MS); one has already died. Withdrawal of the drug, eliminates all hope that it will be allowed back on the market this year, or ever.

8 Mar 2005

Thalidomide - new treatment for cancer

Thalidomide, famous in the 60's because of limb deformities in babies born to women who had taken it for morning sickness, was withdrawn in 1961. Now doctors say it could be used as a treatment for cancer.

8 Mar 2005

HIVMA and AAHIVM urge lawmakers to make medical care the top priority for Ryan White Programs

The nation’s frontline HIV medical providers are calling for an end to waiting lists for essential anti-AIDS drugs that patients need in order to live.

8 Mar 2005

AIDS drug pricing complaint in South Africa against GlaxoSmithKline moves forward

A landmark South African legal complaint against British drug maker GlaxoSmithKline (GSK) over its AIDS drug pricing and policies in that country will proceed following an order late last week by South Africa's Competition Tribunal that will allow the complaint to go forward.

8 Mar 2005